¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"reduced penetrance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduced penetrance
    °¨Åð¹ßÇö
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • penetrance
    1. Åõ°úµµ, Åõ°ú 2. ħÅõµµ
  • reduced bandwidth technique
    Á֯ļöÆø°¨¼Ò±â¹ý
  • reduced flavoprotein
    ȯ¿øÇüÇöóºó´Ü¹éÁú
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò, ȯ¿øÇì¸ð±Û·Îºó
  • reduced pelvis
    Ãà¼Ò°ñ¹Ý
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò
  • penetrance
    Åõ°úµµ, ¹æ»çÅõ°úµµ, Åõ°ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduced penetrance
    °¨Åð¹ßÇö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • penetrance
    Åõ°úµµ, ¹æ»çÅõ°úµµ, Åõ°ú
  • reduced flavoprotein
    ȯ¿øÇüÇöóºó´Ü¹éÁú
  • reduced heat
    ȯ»ê¿­·®
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò
  • reduced pelvis
    ÇùÂø°ñ¹Ý, Ãà¼Ò°ñ¹Ý
  • reduced bandwidth technique
    Á֯ļöÆø°¨¼Ò±â¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduced penetrance
    ¹ßÇö¼º °¨Åð(Û¡úÞàõÊõ÷Ü).
  • reduced penetrance
    ¹ßÇö¼º °¨Åð(Û¡úÞàõÊõ÷Ü)
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Gullstrands reduced eye
    ±¼½ºÆ®¶õµå»ý·«¾È
  • reduced bandwidth technique
    Á֯ļöÆø °¨¼Ò ±â¹ý
  • reduced body temperature
    Àúü¿Â(¹ý) (î¸ô÷è®Ûö).
  • reduced eye
    »ý·«¾È(ßèå²äÑ).
  • reduced flavoprotein
    ȯ¿øÇüÇö󺸴ܹéÁú.
  • reduced heat
    ȯ»ê¿­·®(üµß©æðåÖ).
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò(ü½êª úìßäáÈ).
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò(ü½êªúìßäáÈ)
  • reduced illumination
    °¨¾àÁ¶¸í(˧ËâÌ¡ËÎ).
  • reduced iron ³ª ferrum reductum
    ȯ¿øÃ¶(ü½êªôÑ).
  • reduced mass
    ȯ»êÁú·®(üµß©òõåÖ).
  • reduced pelvis
    ÇùÂø°ñ¹Ý(úõó¸ÍéÚï)
  • reduced pressure
    °¨¾Ð(˧Ëâ), ȯ»ê¾Ð·Â.
  • reduced temperature
    Àú¿Â(î¸è®).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduced penetrance
    ¹ßÇö¼º °¨Åð(Û¡úÞàõÊõ÷Ü).
  • reduced penetrance
    ¹ßÇö¼º °¨Åð(Û¡úÞàõÊõ÷Ü)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • incomplete penetrance
    ºÒ¿ÏÀüÅõ°úµµ
  • penetrance
    ¹æ»ç (ÀÇ)Åõ°úµµ(÷âΦöô).
  • penetrance
    Åõ°úµµ(÷âΦÓñ)
  • penetrance,mendelian
    ¸àµ¨¼º(¡­àõ)
  • edema,reduced oncotic pressure
    »ïÅõ¾Ð °¨¼Ò(ß¶÷âäâ Êõá´)
  • reduced bandwidth technique
    Á֯ļöÆø °¨¼Ò ±â¹ý
  • reduced body temperature
    Àúü¿Â(¹ý) (î¸ô÷è®Ûö).
  • reduced eye
    »ý·«¾È(ßèå²äÑ).
  • reduced flavoprotein
    ȯ¿øÇüÇö󺸴ܹéÁú.
  • reduced heat
    ȯ»ê¿­·®(üµß©æðåÖ).
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò(ü½êªúìßäáÈ)
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò(ü½êª úìßäáÈ).
  • reduced illumination
    °¨¾àÁ¶¸í(˧ËâÌ¡ËÎ).
  • reduced iron ³ª ferrum reductum
    ȯ¿øÃ¶(ü½êªôÑ).
  • reduced mass
    ȯ»êÁú·®(üµß©òõåÖ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduced mean residue rotation
    ȯ»ê Æò±Õ Àܱâ ȸÀü(üµß©øÁгíÑÐñüÞï®)
  • reduced osmotic pressure
    ȯ»ê »ïÅõ¾Ð(üµß©ß¶÷âäâ)
  • reduced scattered light intensity
    ȯ»ê »ê¶õ±¤ °­µµ(üµß©ß¤Õ¯ÎÃË­Óø)
  • reduced substrate concentration
    ȯ»ê ±âÁú ³óµµ(üµß©Ñ¨òõÒØÓø)
  • reduced viscosity
    ȯ»ê Á¡µµ(üµß©ïÄÓø)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduced
    °¨ÅðÇÑ
  • reduced bandwidth technique
    ´ëÆø°¨¼Ò±â¹ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DPNH reduced diphosphopyridine nucleotide
FADH2 reduced form of flavin adenine dinucleotide
FMNH, FMNH2 reduced form of flavin mononucleotide
FPH2 reduced form of flavin phosphate
G6PDH, G-6-PDH glucose-6-phosphate dehydrogenase reduced
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
rcm Reduced and carboxymethylated
RFC Reduced folate carrier
RHAL Reduced haloperidol
RRM Reduced renal mass
SCR SEX COMBS REDUCED
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • penetrance
    ħÅõµµ
  • reduced
    °¨ÅðÇÑ
    1. °ñÀýÀÇ Á¤º¹°ú °°ÀÌ ÀûÀýÇÑ À§Ä¡, ¹èÄ¡¿¡ µÇµ¹¸°. 2. ±Ý¼ÓÀÇ ÇüÀ¸·Î µÇµ¹¸°.
  • reduced dental epethelium
    ÅðÃà Ä¡»óÇÇ
  • reduced interoccusal distance
    ÀúÀ§ ±³ÇÕ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
genetic penetrance The extent to which a genetically determined condition is expressed in an individual.
(05 Mar 2000)
penetrance The proportion of individuals with a specific genotype who express that character in the phenotype.
(18 Nov 1997)
reduced enamel epithelium The several layers of the enamel organ remaining on the enamel surface after formation of enamel is completed.
Synonym: reduced enamel epithelium.
(05 Mar 2000)
reduced eye A simplified design of the ocular optical system, represented as having a single refracting surface and a uniform index of refraction; a model based on this concept is used in retinoscopy and ophthalmoscopy.
(05 Mar 2000)
reduced glutathione Glutathione acting as a hydrogen donor.
(05 Mar 2000)
reduced haematin 1. <biochemistry> Compounds of iron complexed in a porphyrin (tetrapyrrole) ring that differ in side chain composition. Haems are the prosthetic groups of cytochromes and are found in most oxygen carrier proteins.
2. <prefix> haem-, eaning relating to blood.
Origin: G. Haima
(21 Jun 2000)
reduced haemoglobin The form of Hb in red blood cells after the oxygen of oxyhemoglobin is released in the tissues.
(05 Mar 2000)
reduced interarch distance An occluding vertical dimension which results in an excessive interocclusal distance when the mandible is in rest position, and in a reduced interridge distance when the teeth are in contact.
(05 Mar 2000)
Listing's reduced eye A representation that simplifies calculations of retinal imagery: radius of anterior refracting surface, 5.1 mm; total length, 20 mm; distance of nodal point to retina, 15 mm.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduced
    ÁÙÀÎ;Ãà¼ÒÇÑ;°¨¼ÒÇÑ;ÇÒÀÎÇÑ;¿µ¶ôÇÑ;¸ô¶ôÇÑ;¼è¾àÇÑ;ȯ¿øÇÑ;±â¾àÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á